November 9, 2016 - November 22, 2016

GreenSignal Bio Pharma IPO Review & Recommendations

Dilip Davda has given "Apply" recommendation to GreenSignal Bio Pharma IPO.

GreenSignal Bio Pharma IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	1	0	0	0	0
%	100.00	0.00	0.00	0.00	0.00

GreenSignal Bio Pharma IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Apply

GreenSignal Bio Pharma IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for GreenSignal Bio Pharma IPO is 25. Their analysis recommends Do not subscribe for the IPO.

Reviewer	Rating Score	Rating
Capital Market	25	Do not subscribe

GreenSignal Bio Pharma IPO Review by Dilip Davda (Apply)

[Dilip Davda] This Company will enjoy first mover advantage in the important generic vaccine sector and will attract fancy going forward. Moderate investment may be considered for long term rewards as the issue size is small and will attract T segment listing for initial period due to which, short term rewards unlikely. Read detail review...

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.